ticagrelor
coronary medication
Facts
17 properties- Instance of
- type of chemical entity
- Subclass of
- 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol[5]
- Has use
- medication[6]
- Active ingredient in
- Brilique, Possia, Brilinta
- Canonical SMILES
- CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO[3]
- Chemical formula
- C₂₃H₂₈F₂N₆O₄S[4]
- Defined daily dose
- 0.18 g
- Has active ingredient
- Ticagrelor
- Isomeric SMILES
- CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO
- Legal status (medicine)
- boxed warning
- Mass
- 522.186 Da
- Medical condition treated
- acute myocardial infarction, unstable angina, acute coronary syndrome, heart disease
- Physically interacts with
- Purinergic receptor P2Y12[2]
- Pregnancy category
- US pregnancy category C
- Significant drug interaction
- nabumetone, naproxen, celecoxib, Diclofenac, piroxicam, meloxicam, (RS)-fenoprofen, (±)-flurbiprofen, ibuprofen, indomethacin, (RS)-ketoprofen, (RS)-etodolac
+27 more
sulindac, parecoxib, aceclofenac, tenoxicam, vortioxetine, ibrutinib, paroxetine, sertraline, fluvoxamine, fluoxetine, (RS)-citalopram, aspirin, anagrelide, enoxaparin, dalteparin, urokinase, tinzaparin, rac-warfarin, fondaparinux, alteplase, heparin, acenocoumarol, phenindione, tenecteplase, streptokinase, rivaroxaban, apixaban - Subject has role
- xenobiotic-transporting ATPase inhibitor, purinergic P2Y receptor antagonists
- World Health Organisation international non-proprietary name
- ticagrelor
🏷️ Also known as
en ticagrelor
en Ticagrelor
en (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
en (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
en AR-C126532XX
en AZD 6140
en AZD-6140
en AZD6140
en Brilinta®
en Brilique®
ar تيكاغريلور
cs tikagrelor
fa تیکاگرلور
fr C23H28F2N6O4S
he טיקגרלור
ja チカグレロル
ko 티카그렐러
pt Brilinta
uk тикагрелор
zh 替卡格雷
🔖 Identifiers · 39
- OpenAlex ID
- C2780890252
- ATC code
- B01AC24
- CAS Registry Number
- 274693-27-5
- ChEBI ID
- 68558
- ChEMBL ID
- CHEMBL398435
- ChemSpider ID
- 8047109
- DSSTOX compound identifier
- DTXCID501436166
- DSSTox substance ID
- DTXSID901009337
- DeCS ID
- 57659
- DrugBank ID
- DB08816
- DrugCentral ID
- 4184
- EC number
- 619-540-9
Show all 39 identifiers +27
- ECHA Substance Infocard ID
- 100.114.746
- Freebase ID
- /m/04jcnlb
- Guide to Pharmacology Ligand ID
- 1765
- HSDB ID
- 8306
- Human Metabolome Database ID
- HMDB0015702
- IEDB Epitope ID
- 244317
- InChIKey
- OEKWJQXRCDYSHL-FNOIDJSQSA-N
- KEGG ID
- D09017
- MeSH descriptor ID
- D000077486
- MeSH tree code
- D03.633.100.759.590.138.806, D13.570.583.138.806, D13.570.800.096.815
- MedlinePlus drug identifier
- a611050
- Microsoft Academic ID (discontinued)
- 2780890252
- NDF-RT ID
- N0000182973
- National Drug Code
- 72516-017, 42571-282, 84206-0093, 55488-0543, 77771-522, 49587-109, 58032-2032, 65372-1198, 82712-1001, 43598-629, 60505-4453, 0378-2215
+38 more
17228-7777, 45941-3055, 62331-065, 82245-0122, 50228-521, 50228-522, 50268-826, 60505-4452, 69452-508, 71610-914, 72516-018, 77771-521, 58623-0131, 83137-0001, 69097-989, 70756-047, 70756-048, 71610-958, 46708-883, 50379-0023, 75945-902, 33342-431, 46708-500, 60687-935, 67877-522, 72205-368, 17228-0777, 53747-092, 69037-0007, 82708-0017, 33342-432, 42658-115, 46708-241, 51407-861, 55488-0544, 60687-928, 67877-491, 72205-406 - PDB ligand ID
- TIQ
- PatientsLikeMe treatment ID
- ticagrelor
- Probes And Drugs ID
- PD009197
- PubChem CID
- 9871419
- Reaxys registry number
- 15468079
- RxNorm CUI
- 1116632
- SureChEMBL ID
- 1979652
- UMLS CUI
- C1999375
- UNII
- GLH0314RVC
- UniChem compound ID
- 18217
- WikiProjectMed ID
- Ticagrelor
🔗 Connections
Significant drug interaction 36
← Significant drug interaction 36
Medical condition treated 4
← Drug or therapy used for treatment 4
Has use 1
Legal status (medicine) 1
Press Enter · cited answer in seconds
0 sources
Summary
ticagrelor is a type of chemical entity[1].